Skip to content

Spectral AI, Inc. MDAI Fair Value Adjustment Of Warrants

Fair Value Adjustment Of Warrants at other companies

Biodesix, Inc. logo
Biodesix, Inc.BDSX
$200K

Other financials

Income statement

See full
Revenue$4.0M-40.5%
Gross profit$2.0M-36.0%
Operating income-$2.0M-120%
Net income-$3.4M-218%
EPS (diluted)-$0.11-200%

Balance sheet

See full
Cash & equivalents$11.7M-17.1%
Total debt$6.0M-36.6%
Total equity-$8.8M-442%
Total assets$17.7M-14.4%

Cash flow

See full
Operating cash flow-$3.7M-148%

Valuation

See full
Market cap$55.06M+3.9%
Enterprise value$49.43M-4.8%
P/S3.3×+1.3×

Profitability

See full
Gross margin46%+0.9pp
Operating margin-57.2%-104pp
Net margin-70%+176pp

Returns & leverage

See full
Return on equity-255.5%
Debt / equity0.7×+0.7×
Current ratio0.8×-0.7×

Where this comes from

Reported directly by Spectral AI, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FairValueAdjustmentOfWarrants.

The official record: Spectral AI, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Spectral AI, Inc.'s fair value adjustment of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Spectral AI, Inc.'s fair value adjustment of warrants?
Spectral AI, Inc. (MDAI) reported fair value adjustment of warrants of $1M in Q1 2026.
How has Spectral AI, Inc.'s fair value adjustment of warrants changed year-over-year?
Spectral AI, Inc.'s fair value adjustment of warrants increased by 123.6% year-over-year, from -$4.25M to $1M.
What is the long-term trend for Spectral AI, Inc.'s fair value adjustment of warrants?
Over 2 years (2022 to 2025), Spectral AI, Inc.'s fair value adjustment of warrants has grown at a 280.6% compound annual growth rate (CAGR), from -$8.86M to $128.3M.
What does fair value adjustment of warrants mean?
The periodic change in the estimated market value of outstanding warrants issued by the company. These adjustments are non-cash items that reflect market volatility and the company's valuation of its own equity-linked derivatives.